Personal ECG or EKG devices are used for self-monitoring of heart function at home or on the move. These devices well suited for people with increased health risks caused by high blood pressure, increased cholesterol, hereditary medical risks, and stress. It can also detect significant rhythm abnormalities. There are no patches, wires, or gels required and it records heart data connected via smartphone. According to United States Centers for Disease Control and Prevention, an estimated 3-6 million Americans have atrial fibrillation, or AFib, the most common type of heart arrhythmia.This growth is primarily driven by Rise in the Number of Patients with Cardiovascular Diseases in North America and Growing Demand for Portable e-Health Devices.
Globally, a noticeable market trend is evident Compatibility of Devices with Android and iOS Smartphones and Tablets
. Major Players, such as Cardiocomm Solutions Inc. (The HeartCheck) (Canada), AliveCor, Inc. (United States), OMRON Corporation (Japan), PocketECG (Poland), Beurer GmbH (Germany), Zenicor Medical Systems AB (Sweden), Schiller AG (Switzerland), Lohman Technologies (AfibAlert) (United States), Cardiac Designs Inc. (United States) and iRhythm Technologies, Inc. (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
Key Developments in the Market:
On April 23, 2020, AliveCor, and OMRON, a global leader in personal heart health and wellness technology, formed a strategic alliance that combines AliveCorís ECG technology with industry-leading blood pressure devices from OMRON to serve customers and expand access to remote patient care.
On November 24, 2020, The United States Food and Drug Administration has cleared AliveCor's next generation of interpretive artificial intelligence-based personal electrocardiogram algorithms, Kardia AI V2, the most sophisticated AI to personal ECG. and On Sept 25, 2020, AliveCor, enters the Indian market with the launch of its clinically validated personal ECG device, KardiaMobile 6L.
Personal ECG Devices are regulated and approved by the Food and Drug Administration (FDA), 510(k).
- Rise in the Number of Patients with Cardiovascular Diseases in North America
- Growing Demand for Portable e-Health Devices
- Compatibility of Devices with Android and iOS Smartphones and Tablets
- Mobile Cardiac Telemetry Monitoring
- Availability of in-Hospital Conventional ECG Machines
Technological Advancements such as Artificial Intelligence, Cloud-based System, and Bluetooth in Medical Care and Innovations in Sensor Technologies to Record Electric Impulses, Wearable Technologies
Lack of Awareness About the Personal ECG Devices
AdvanceMarketAnalytics follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.
Customization of the Report:
AMA Research & Media features not only specific market forecasts, but also include significant value-added commentary on:
Technological Trends and Innovations
Regulatory Trends & Policies
Market Maturity Indicators
Market Share Movements
Growth Drivers and Constraints
New Entrants into the Market & Entry/Exit Barriers
Supporting Company Financial and Cash Flow Planning
Open Up New Markets
To Seize Powerful Market Opportunities
Key Decision in Planning and to Further Expand Market Share
Identify Key Business Segments, Market Proposition & Gap Analysis